These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 29728105)

  • 1. Identifying risk factors for L'Hermitte's sign after IMRT for head and neck cancer.
    Laidley HM; Noble DJ; Barnett GC; Forman JR; Bates AM; Benson RJ; Jefferies SJ; Jena R; Burnet NG
    Radiat Oncol; 2018 May; 13(1):84. PubMed ID: 29728105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lhermitte sign after chemo-IMRT of head-and-neck cancer: incidence, doses, and potential mechanisms.
    Pak D; Vineberg K; Feng F; Ten Haken RK; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1528-33. PubMed ID: 22284690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lhermitte's Sign following VMAT-Based Head and Neck Radiation-Insights into Mechanism.
    Ko HC; Powers AR; Sheu RD; Kerns SL; Rosenstein BS; Krieger SC; Mourad WF; Hu KS; Gupta V; Bakst RL
    PLoS One; 2015; 10(10):e0139448. PubMed ID: 26448647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lhermitte sign and myelopathy after irradiation of the cervical spinal cord in radiotherapy treatment of head and neck cancer.
    Mul VE; de Jong JM; Murrer LH; van den Ende PL; Houben RM; Lacko M; Lambin P; Baumert BG
    Strahlenther Onkol; 2012 Jan; 188(1):71-6. PubMed ID: 22194023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton beam radiation therapy results in significantly reduced toxicity compared with intensity-modulated radiation therapy for head and neck tumors that require ipsilateral radiation.
    Romesser PB; Cahlon O; Scher E; Zhou Y; Berry SL; Rybkin A; Sine KM; Tang S; Sherman EJ; Wong R; Lee NY
    Radiother Oncol; 2016 Feb; 118(2):286-92. PubMed ID: 26867969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing 3DCRT and inversely optimized IMRT planning for head and neck cancer: equivalence between step-and-shoot and sliding window techniques.
    Longobardi B; De Martin E; Fiorino C; Dell'oca I; Broggi S; Cattaneo GM; Calandrino R
    Radiother Oncol; 2005 Nov; 77(2):148-56. PubMed ID: 16260056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IMRT: preliminary results in a series of advanced head-and-neck cancer patients.
    Vila Capel A; Vilar Palop J; Pedro Olivé A; Sanchez-Reyes Fernandez A; Vayreda Ribera J; Julià Sanahuja JC; Pérez de Olaguer Agustín J; Artola Codina N; Moya Cascant LM; Rubio Calatayud E; Carrera Domenech G
    Clin Transl Oncol; 2013 Mar; 15(3):233-42. PubMed ID: 22855193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute hematologic and mucosal toxicities in head and neck cancer patients undergoing chemoradiotherapy: a comparison of 3D-CRT, IMRT, and helical tomotherapy.
    Kruser TJ; Rice SR; Cleary KP; Geye HM; Tome WA; Harari PM; Kozak KR
    Technol Cancer Res Treat; 2013 Oct; 12(5):383-9. PubMed ID: 23547974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole-Field Sequential Intensity-Modulated Radiotherapy for Local-Regional Advanced Head-and-Neck Squamous Cell Carcinoma.
    Refaat T; Choi M; Thomas TO; Bacchus I; Agulnik M; Pelzer HJ; Mellott AL; Rademaker AW; Liu D; Sathiaseelan V; Mittal BB
    Am J Clin Oncol; 2015 Dec; 38(6):588-94. PubMed ID: 24136140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lhermitte's sign among nasopharyngeal cancer patients after radiotherapy.
    Leung WM; Tsang NM; Chang FT; Lo CJ
    Head Neck; 2005 Mar; 27(3):187-94. PubMed ID: 15627248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [SIB-IMRT radiotherapy given concomitantly with cisplatin for locally advanced squamous cell head and neck cancer (SCHNC). Evaluation of the early results and toxicity].
    Kiprian D; Jarząbski A; Pawłowska B; Michalski W; Kawecki A
    Otolaryngol Pol; 2011 Sep; 65(5 Suppl):117-25. PubMed ID: 22000261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent cisplatin and dose escalation with intensity-modulated radiotherapy (IMRT) versus conventional radiotherapy for locally advanced head and neck squamous cell carcinomas (HNSCC): GORTEC 2004-01 randomized phase III trial.
    Tao Y; Auperin A; Blanchard P; Alfonsi M; Sun XS; Rives M; Pointreau Y; Castelli J; Graff P; Wong Hee Kam S; Thariat J; Veresezan O; Heymann S; Renard-Oldrini S; Lafond C; Cornely A; Casiraghi O; Boisselier P; Lapeyre M; Biau J; Bourhis J
    Radiother Oncol; 2020 Sep; 150():18-25. PubMed ID: 32417348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord.
    Chau RM; Teo PM; Kam MK; Leung SF; Cheung KY; Chan AT
    Med Dosim; 2007; 32(4):263-70. PubMed ID: 17980826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spot-scanning beam proton therapy vs intensity-modulated radiation therapy for ipsilateral head and neck malignancies: a treatment planning comparison.
    Kandula S; Zhu X; Garden AS; Gillin M; Rosenthal DI; Ang KK; Mohan R; Amin MV; Garcia JA; Wu R; Sahoo N; Frank SJ
    Med Dosim; 2013; 38(4):390-4. PubMed ID: 23916884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intensity-modulated radiotherapy of head and neck cancers. Dose constraint for spinal cord and brachial plexus].
    Boisselier P; Racadot S; Thariat J; Graff P; Pointreau Y
    Cancer Radiother; 2016 Oct; 20(6-7):459-66. PubMed ID: 27614529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of cervical radiation myelitis after hyperfractionated radiation therapy with and without concurrent chemotherapy for locally advanced, unresectable, nonmetastatic squamous cell carcinoma of the head and neck.
    Jeremic B; Shibamoto Y; Igrutinovic I
    J Cancer Res Clin Oncol; 2001 Nov; 127(11):687-91. PubMed ID: 11710599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose sparing of brainstem and spinal cord for re-irradiating recurrent head and neck cancer with intensity-modulated radiotherapy.
    Chen CC; Lee CC; Mah D; Sharma R; Landau E; Garg M; Wu A
    Med Dosim; 2011; 36(1):21-7. PubMed ID: 20202815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrent weekly cisplatin and simultaneous integrated boost intensity-modulated radiotherapy of locally advanced squamous cell carcinoma of the head and neck.
    Dubinský P; Jeremic B; Švajdová M; Barilíková G; Matula P; Nadzonová D; Vojtek V
    Klin Onkol; 2022; 35(4):307-314. PubMed ID: 35989088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of the dose to the elective neck in head and neck squamous cell carcinoma, a randomized clinical trial using intensity modulated radiotherapy (IMRT). Dosimetrical analysis and effect on acute toxicity.
    Nuyts S; Lambrecht M; Duprez F; Daisne JF; Van Gestel D; Van den Weyngaert D; Platteaux N; Geussens Y; Voordeckers M; Madani I; De Neve W
    Radiother Oncol; 2013 Nov; 109(2):323-9. PubMed ID: 23953410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
    Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.